Nakamura Y, Nagase I, Asano A, Sasaki N, Yoshida T, Umekawa T, Sakane N, Saito M
Department of Biomedical Sciences, School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
J Vet Med Sci. 2001 Mar;63(3):309-14. doi: 10.1292/jvms.63.309.
Chronic stimulation of the beta3-adrenergic receptor (AR) in obese animals resulted in a reduced adiposity associated with an increased expression of thermogenic uncoupling protein (UCP)1 in adipose tissues. In this study, the mRNA expression of newly cloned UCP isoforms (UCP2 and UCP3) were examined in obese yellow KK and C57BL control mice. UCP2 mRNA was found in all tissues examined, with higher levels in adipose tissues and skeletal muscle of the obese mice. UCP3 mRNA was expressed in skeletal muscle, heart and brown adipose tissue similarly in the two mouse strains. Daily injection of a selective beta3-adrenergic agonist, CL316,243 (0.1 mg/kg), for 10 days resulted in a marked reduction of white fat pad weight and 1.8-4.8-fold increase in the mRNA levels of UCP2 and UCP3 in skeletal muscle of obese mice. No noticeable change in the UCP2 and 3 mRNA levels was found in brown and white adipose tissues. It was also found that CL316,243 injection produced a marked and sustained elevation of the plasma free fatty acid level. These results, together with our previous findings of the fatty acid-induced UCP expression in a myocyte cell line in vitro, suggest that the beta3-AR agonist-induced UCP expression in skeletal muscle may be mediated through the elevated plasma free fatty acids. It was also suggested that anti-obesity effect of beta3-AR agonists is attributable to increased thermogenesis not only by UCP1 but also by UCP2 and UCP3.
对肥胖动物的β3 - 肾上腺素能受体(AR)进行长期刺激,会导致肥胖程度降低,同时脂肪组织中产热解偶联蛋白(UCP)1的表达增加。在本研究中,检测了新克隆的UCP亚型(UCP2和UCP3)在肥胖的黄色KK小鼠和C57BL对照小鼠中的mRNA表达。在所有检测的组织中均发现了UCP2 mRNA,在肥胖小鼠的脂肪组织和骨骼肌中水平更高。在两种小鼠品系中,UCP3 mRNA在骨骼肌、心脏和棕色脂肪组织中的表达情况相似。每天注射选择性β3 - 肾上腺素能激动剂CL316,243(0.1 mg/kg),持续10天,导致肥胖小鼠白色脂肪垫重量显著减轻,骨骼肌中UCP2和UCP3的mRNA水平增加1.8至4.8倍。在棕色和白色脂肪组织中,未发现UCP2和3 mRNA水平有明显变化。还发现注射CL316,243会使血浆游离脂肪酸水平显著且持续升高。这些结果,连同我们之前在体外心肌细胞系中关于脂肪酸诱导UCP表达的发现,表明β3 - AR激动剂诱导骨骼肌中UCP表达可能是通过升高的血浆游离脂肪酸介导的。还表明β3 - AR激动剂的抗肥胖作用不仅归因于UCP1增加的产热,还归因于UCP2和UCP3。